FindMyKOL
Clinical trialNCT03538028CompletedPhase 1Interventional

A Safety and Tolerability Study of INCAGN02385 in Select Advanced Malignancies

SponsorIncyte Biosciences International SàrlEnrollment22Cervical CancerDiffuse Large B-cell LymphomaEsophageal CancerGastric Cancer (Including Stomach and Gastroesophageal Junction [GEJ])Hepatocellular CarcinomaMSI-high Colorectal Cancer+11 more conditions
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to determine the safety, tolerability, and preliminary efficacy of INCAGN02385 in participants with advanced malignancies.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • the Angeles Clinic and Research Center

    Los Angeles, California, United States

  • Hackensack Medical Center

    Hackensack, New Jersey, United States

  • Carolina Biooncology Institute

    Huntersville, North Carolina, United States

  • Vanderbilt University Medical Center

    Nashville, Tennessee, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

INCAGN02385
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
18 Jun 2018
Primary completion
7 Oct 2020
Completion
7 Oct 2020
Last update posted
30 Oct 2020
Registered enrollment
22
Registry id
NCT03538028
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.